{"id":"W4381336812","doi":"10.1093/bjd/ljad162.037","title":"417 Safety of long-term dupilumab treatment in adults with moderate-to-severe atopic dermatitis: results from an open-label extension trial up to 5 years","year":2023,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada)","funders":"","keywords":"Dupilumab; Atopic dermatitis; Medicine; Eczema Area and Severity Index; Concomitant; Adverse effect; Internal medicine; Clinical trial; Open label; Dermatology; Randomized controlled trial; Population","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002582674,0.0006418977,0.001400873,0.0002203512,0.0004714048,0.0009675185,0.0004070831,0.001345015,0.003139324],"category_scores_gemma":[0.001802001,0.0002669735,0.002513561,0.0002683454,0.0006510569,0.0008793694,0.000362561,0.002097647,0.0007506956],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000638623,"about_ca_system_score_gemma":0.0008321199,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004474384,"about_ca_topic_score_gemma":0.001141473,"domain_scores_codex":[0.9988933,0.0005028555,0.0001193857,0.0001741043,0.0001387361,0.0001715476],"domain_scores_gemma":[0.9982566,0.0004013616,0.0004770579,0.0001800179,0.0002343172,0.0004506587],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.857347,0.02282062,0.01057689,0.001350425,0.002584122,0.0002083294,0.0002247015,0.000508854,0.01543989,0.0001646645,0.002218396,0.08655615],"study_design_scores_gemma":[0.3322194,0.5997512,0.05422704,0.0002101413,0.002816526,0.0003944663,0.0001202584,0.0007853807,0.003300545,0.0002317833,0.0058875,0.0000556644],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880356,0.007376306,0.0003270038,0.0003104791,0.0001564573,0.0009400584,0.001166238,0.00003790698,0.001649977],"genre_scores_gemma":[0.9928484,0.001994623,0.0005464985,0.0007527989,0.000232358,0.0008522532,0.001653704,0.000008157227,0.001111081],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003139324,"threshold_uncertainty_score":0.01365864,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02885390551996612,"score_gpt":0.3123646391844421,"score_spread":0.2835107336644759,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}